DK0822200T3 - Syntese af analoger til PTH og PTrP - Google Patents

Syntese af analoger til PTH og PTrP

Info

Publication number
DK0822200T3
DK0822200T3 DK97112595T DK97112595T DK0822200T3 DK 0822200 T3 DK0822200 T3 DK 0822200T3 DK 97112595 T DK97112595 T DK 97112595T DK 97112595 T DK97112595 T DK 97112595T DK 0822200 T3 DK0822200 T3 DK 0822200T3
Authority
DK
Denmark
Prior art keywords
ptrp
pth
analogs
synthesis
Prior art date
Application number
DK97112595T
Other languages
English (en)
Inventor
Humberto Bartolome Arzeno
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0822200T3 publication Critical patent/DK0822200T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97112595T 1996-07-30 1997-07-23 Syntese af analoger til PTH og PTrP DK0822200T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2332296P 1996-07-30 1996-07-30
EP97112595A EP0822200B1 (en) 1996-07-30 1997-07-23 Synthesis of analogs of PTH and PTrP

Publications (1)

Publication Number Publication Date
DK0822200T3 true DK0822200T3 (da) 2005-01-31

Family

ID=21814418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97112595T DK0822200T3 (da) 1996-07-30 1997-07-23 Syntese af analoger til PTH og PTrP

Country Status (30)

Country Link
US (1) US6849710B1 (da)
EP (1) EP0822200B1 (da)
JP (1) JP4229992B2 (da)
KR (1) KR100518982B1 (da)
CN (1) CN1293096C (da)
AR (2) AR008094A1 (da)
AT (1) ATE277080T1 (da)
AU (1) AU731160B2 (da)
BR (1) BR9704138A (da)
CA (1) CA2206008C (da)
CO (1) CO4650046A1 (da)
CZ (1) CZ239697A3 (da)
DE (1) DE69730787T2 (da)
DK (1) DK0822200T3 (da)
ES (1) ES2227639T3 (da)
HR (1) HRP970416A2 (da)
HU (1) HUP9701277A3 (da)
IL (1) IL121391A0 (da)
MA (1) MA24353A1 (da)
MX (1) MX9705719A (da)
NO (1) NO973482L (da)
NZ (1) NZ328411A (da)
PE (1) PE91998A1 (da)
PL (1) PL321391A1 (da)
SG (1) SG67408A1 (da)
TR (1) TR199700714A2 (da)
TW (1) TW505654B (da)
UY (1) UY24651A1 (da)
YU (1) YU32197A (da)
ZA (1) ZA976555B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003207512B2 (en) * 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
WO2007059470A2 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
BRPI0706400A2 (pt) * 2006-01-17 2011-03-29 Organon Nv processos para a hidrólise enzimática seletiva de terc-butil ésteres c-terminais de substratos de peptìdeo, para a sìntese convergente de um peptìdeo de dois ou mais fragmentos de peptìdeo, para a sìntese enzimática por etapas de um peptìdeo na direção do terminal c, e para a sìntese de peptìdeo
MX2009003569A (es) 2006-10-03 2009-08-25 Radius Health Inc Metodo de administracion de farmacos para la proteina anabolica osea.
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
CN102731643A (zh) * 2012-06-26 2012-10-17 深圳翰宇药业股份有限公司 一种治疗骨质疏松多肽的制备方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
SG11201506885UA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of cyclic imide containing peptide products
AU2014234400B2 (en) 2013-03-21 2017-11-16 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
CN104530198B (zh) * 2014-12-09 2017-09-15 兰州大学 一种片段缩合制备醋酸去氨加压素的方法
AU2016256470B2 (en) 2015-04-29 2020-10-15 Radius Pharmaceuticals, Inc. Methods of treating cancer
LT3565542T (lt) 2017-01-05 2024-07-10 Radius Pharmaceuticals, Inc. Polimorfinės rad1901-2hcl formos
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
WO2019175173A1 (en) * 2018-03-12 2019-09-19 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of pthrp analogue
CN112423844B (zh) 2018-07-04 2024-08-13 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
CN111057139B (zh) * 2018-10-17 2023-12-22 南京华威医药科技集团有限公司 一种制备特立帕肽的新工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
AU667662B2 (en) * 1990-07-13 1996-04-04 Regents Of The University Of California, The Parathyroid hormone analogues modified at positions 3, 6 or 9
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
ATE277080T1 (de) 2004-10-15
HU9701277D0 (en) 1997-09-29
NO973482L (no) 1998-02-02
EP0822200A1 (en) 1998-02-04
DE69730787T2 (de) 2005-10-13
HRP970416A2 (en) 1998-08-31
AU3236297A (en) 1998-02-05
CO4650046A1 (es) 1998-09-03
NO973482D0 (no) 1997-07-29
DE69730787D1 (de) 2004-10-28
HUP9701277A2 (hu) 1998-11-30
PL321391A1 (en) 1998-02-02
JP4229992B2 (ja) 2009-02-25
YU32197A (sh) 1999-07-28
AR016981A2 (es) 2001-08-01
HUP9701277A3 (en) 2001-02-28
JPH1077295A (ja) 1998-03-24
EP0822200B1 (en) 2004-09-22
TW505654B (en) 2002-10-11
TR199700714A2 (xx) 1998-02-21
KR980009282A (ko) 1998-04-30
PE91998A1 (es) 1998-12-31
CA2206008A1 (en) 1998-01-30
CN1293096C (zh) 2007-01-03
AR008094A1 (es) 1999-12-09
KR100518982B1 (ko) 2006-05-29
MX9705719A (es) 1998-02-28
MA24353A1 (fr) 1998-07-01
SG67408A1 (en) 1999-09-21
UY24651A1 (es) 2000-12-29
AU731160B2 (en) 2001-03-22
CN1174845A (zh) 1998-03-04
ES2227639T3 (es) 2005-04-01
IL121391A0 (en) 1998-01-04
BR9704138A (pt) 1998-12-29
CA2206008C (en) 2008-09-23
ZA976555B (en) 1998-01-30
NZ328411A (en) 1998-12-23
CZ239697A3 (cs) 1998-04-15
US6849710B1 (en) 2005-02-01

Similar Documents

Publication Publication Date Title
DK0822200T3 (da) Syntese af analoger til PTH og PTrP
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
DK0807086T3 (da) Fremgangsmåde til fremstilling af hydrotalciter
DK0773940T4 (da) Fremgangsmåde til syntese af substituerede sulfoxider
DK0757684T3 (da) Fremgangsmåde til diastereoselektiv syntese af nucleosidanaloger
DK0647121T3 (da) Apparat til opnåelse af arteriebiopsier
DE69413052D1 (de) Sprachsynthese
DK0672057T3 (da) Analoger af PTH
DK24791A (da) Oevelsesapparat til indoevelse af punktering af blodaarer
DK0706170T3 (da) Fremgangsmåde til talesyntese ved hjælp af sammenkædning og delvis overlapning af bølgeformer
DK1192981T3 (da) Afsvovlingsmiddel og fremgangsmåde til afsvovling af carbonhydrider
DK0468966T3 (da) Syntese af carbonylforbindelser
DK0411084T3 (da) Syntese af hydrocarbylaminer
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
DE69839396D1 (de) Schaltung zur taktwiederherstellung
NO983913D0 (no) Fremgangsmåte for oppfanging av tioler
DK1003528T3 (da) Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater
DK75289A (da) Fremgangsmaade til fremstilling af antihypercholesterolemiske tetrazolforbindelser og mellemprodukter derved
DE69835190D1 (de) Schaltung zur Taktrückgewinnung
BR9711363A (pt) Sintese de bis-indolilmaleimidas
DK149890A (da) Fremgangsmaade til rekonditionering af stoebesand
DK0842930T3 (da) Fremgangsmåde til syntese af benzothiophener
DK0970467T3 (da) Fremgangsmåde til talesyntese
DK1023279T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
BR9708718A (pt) Sínteses de aminas substituídas